Weekly Digest: Breaking Evidence and Policies on Weight Management, Healthy Living, and Nutrition

The World Health Organization (WHO) has published its first-ever global guideline on the use of GLP-1 medicines to treat obesity, a condition affecting over 1 billion people worldwide and projected to double by 2030. This landmark recognition of obesity as a chronic disease emphasizes that medication alone is insufficient. It must be accompanied by sustainable lifestyle changes including healthy diet and physical activity. Despite the promise of GLP-1 therapies, access remains limited with projections estimating less than 10% coverage of eligible populations by 2030. The economic burden of obesity is colossal, expected to reach $3 trillion globally by 2030.

Recent studies shed new light on the power of physical activity to reduce cardiovascular and all-cause mortality risks. One study revealed that brief, continuous walking sessions lasting just 10 to 15 minutes can reduce cardiovascular disease risk by up to 67% and lower all-cause mortality by 83%, outperforming frequent shorter walks. Each additional 1,000 steps daily correlates to a 17% reduction in major adverse cardiovascular events, and in people averaging fewer than 8,000 steps per day, heart failure risk was reduced by 22% per additional 1,000 steps.

Complementing this, a comprehensive study published in Circulation found that exceeding recommended physical activity guidelines (150-300 minutes/week moderate to vigorous exercise) by 2-4 times yields the greatest mortality benefits with reductions of 35-42%. Even moderate levels of activity between 300 and 599 minutes weekly were associated with a 26-31% reduction in all-cause mortality and 28-38% decrease in cardiovascular deaths compared to sedentary lifestyles. This data underscores that increased exercise dosage improves longevity, with diminishing returns beyond 600 minutes per week.

In a concerning development linking obesity with neurodegenerative disease, new biomarker research demonstrates that obesity accelerates Alzheimer's disease progression. Blood biomarker levels indicative of tau proteins increased 95% faster in obese individuals, with neurofilament light chain levels rising 24% faster, suggesting accelerated brain pathology. This is the first direct evidence from blood-based biomarkers linking obesity to faster Alzheimer's combined pathology, highlighting significant public health importance of weight management beyond cardiovascular disease.

On the policy front, the USDA has signed six new state waivers allowing restrictions on unhealthy food purchases under the Supplemental Nutrition Assistance Program (SNAP) in Hawaii, Missouri, North Dakota, South Carolina, Virginia, and Tennessee effective 2026. This marks progress in the "Make America Healthy Again" initiative aiming to curb the chronic disease epidemic by improving nutritional quality among low-income populations dependent on food assistance. Currently, 12 states have adopted these nutrition reforms under SNAP, focusing on removing unhealthy foods to promote healthier eating patterns at scale.

Sources

• https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
• https://www.sciencedaily.com/releases/2025/10/251027224829.htm
• https://www.ama-assn.org/public-health/prevention-wellness/massive-study-uncovers-how-much-exercise-needed-live-longer
• https://www.powershealth.org/about-us/newsroom/health-library/2025/12/02/obesity-could-speed-alzheimers-progression-study-suggests
• https://www.usda.gov/about-usda/news/press-releases/2025/12/10/secretary-rollins-signs-six-new-state-waivers-make-america-healthy-again-removing-unhealthy-foods